Our research group works on the design and development of new drugs and pharmacological tools, aimed at the treatment and diagnosis of neurodegenerative diseases and cancer. We use modern methodologies of organic synthesis, as well as innovative tools and concepts specific to medical chemistry research, for their eventual application in medicine.
- Synthesis and development of new PET radiotracers for the in vivo diagnosis of Alzheimer’s disease and other tauopathies.
- New selective drugs against cancer stem cells. A new approach for the treatment of cancer.
- Development of new methods of detection of tumor markers in samples of biological origin.